Rigel Pharmaceuticals (RIGL) PT Lowered to $6 at JPMorgan
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.18 +0.61%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $6.00 (from $7.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR1,875 at Citi
- Nutex Health (NUTX) PT Raised to $306 at Freedom Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
